Search Results 211-220 of 13885 for Testosterone Propionate

  1. A Study To Test The Combination Of Cabozantinib, Nivolumab, And Ipilimumab (CaboNivoIpi) For Advanced Differentiated Thyroid Cancer - Mayo Clinic

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

  2. A Study Of GSK5458514 Administered Alone Or In Combination With Other Anti-Cancer Agents In Participants With Prostate Cancer - Mayo Clinic

    ... testosterone levels <50 ng/dL, OR (3) bone disease defined by PCWG3 (2 or more lesions on bone scan at screening), as determined by the investigator.

  3. Medical Research & Education - Mayo Clinic News Network

    Innovative Mayo Clinic test may improve mesothelioma detection rate in blood featured image. Individualized Medicine. Innovative Mayo Clinic test may ...

  4. A Study to Test New Technology and Health Coaching to Help People with COPD Become More Physically Active in Their Daily Lives - Mayo Clinic

    The purpose of this study is to test new technology and health coaching aimed to help people with COPD become more physically active in their daily lives.

  5. Clinical trials - Oncology (Medical)

    The purpose of this study is to develop a pan-gynecologic cancer detection test using gynecologic (unique endometrial, cervical, and ovarian cancer) cancer ...

  6. Benign prostatic hyperplasia (BPH) - Diagnosis and treatment - Mayo Clinic

    This exam is likely to include: Digital rectal exam. The provider inserts a finger into your rectum to check if your prostate is enlarged. Urine test. A lab ...

  7. TN-401, A Recombinant Adeno-associated Virus Serotype 9 (AAV9) Containing Plakophilin-2 (PKP2) Transgene, In Adults With PKP2 Mutation-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) - Mayo Clinic

    ... test result for HCV, HIV-1/HIV-2 or laboratory evidence of HBV at Screening defined as: Positive test result for HCV antibodies or HCV RNA at Screening;. HBV ...

  8. A Study Of Pembrolizumab (MK-3475) Versus Placebo In Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy In The Treatment Of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

    ... test within 72 hours before the first dose of study treatment. If the urine test cannot be confirmed as negative, a serum pregnancy test is required. In ...

  9. Clinical trials - Oncology (Medical)

    This study will also test what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body ...

  10. Positron emission tomography (PET) scan - Mayo Clinic

    A PET scan can help find and track many health concerns such as cancer, heart disease and brain conditions. Test results may help guide treatment.